Moeller Law Office - Arizona Attorneys Representing Arizona Clients

Avandia (Rosiglitazone) and Strokes

Studies have linked Avandia (Rosiglitazone) to an increased risk of a stroke. The study was done in Canada and found that Avandia increased users risk of a stroke by 27%.

The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (Rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia. [1]

Studies have suggested that the use of Rosiglitazone may be associated with an increased risk of serious cardiovascular events compared with other treatments for type 2 diabetes. [2]

[1] FDA significantly restricts access to the diabetes drug Avandia

[2] Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

Moeller Law Office - Arizona Attorneys Representing Arizona Clients About Moeller Law Office Moeller Law Office Represents Arizona Clients in Avandia Cases Moeller Law Office Representing Arizona Clients in DePuy Hip Replacement Cases Moeller Law Office Represents Denture Cream Poisoning Clients in Arizona News Contact Moeller Law Office in Arizona
Avandia Evaluation Form Is there a class action lawsuit against the makers of Avandia? Is there a recall on Avandia? How is Avandia linked to strokes? How is Avandia linked to heart attacks? How is Avandia linked to diabetes? What are the risks of taking Avandia? What are some of the side effects of Avandia? What is Avandia? Arizona Avandia Lawyers